Navigation Links
Experts Need to Include Children in Research

According to a leading paediatric expert,Scientists will only make real breakthroughs in childrens medicine if they include children in research programmes as well as adults .

Professor John Warner was speaking today at the opening of the Paediatric Research Unit, the UKs first unit solely devoted to paediatric clinical research.

The unit is run by researchers from Imperial College London and St Marys Hospital, and it is based next to the hospitals paediatric wards in Paddington.

Professor Warner, who is Chair in Paediatrics and Head of the Department of Paediatrics at Imperial College and consultant paediatrician at St Marys Hospital, explained that researchers should be designing therapies specifically for children and their problems, rather than scaling down treatments that were created for adults.

In many respects the makeup of children differs from that of adults: they have different metabolisms; their organs are not as mature as adults; and diseases can behave differently in childrens bodies.

To create the best therapies for children we need to include them in our research, said Professor Warner. A lot of paediatricians work doesnt have much of a scientific evidence base and we prescribe drugs by extrapolating from what we know about adult bodies.

We have a desperate need to understand precisely how childrens bodies work so that we can custom-design therapies for them and their problems.

Researchers in the new unit will be investigating many areas including paediatric allergies and how these can be prevented; sleep disturbance and how this affects health and behaviour; new treatments for acute and chronic chest disorders such as bronchiolitis and asthma.

They will also be looking at infectious diseases and immunisation; new treatments for neuromuscular diseases such as Duchenne muscular dystrophy; and prevention of the complications of sickle cel l disease, to name but a few.

Professor Warner said that people should be assured that all research involving children would be carried out ethically and responsibly.

We will of course be operating to the highest ethical standards and we will go to great lengths to ensure the safety of all the children in our care.

If you think something might help children but youre not certain, it is unethical not to do the research and find out. You might be depriving a child of something that could do immense good, explained Professor Warner.

The new 650,000 pound unit includes two outpatient consulting rooms and two ensuite inpatient rooms, with enough space for a child and their parent to sleep in and with a monitoring room between.

It also has a large waiting and play area, a lung function investigation room, a laboratory, offices for staff, a reception and a treatment room.

The first studies to be conducted by the unit will be a trial looking at preventing allergies using prebiotics in high risk infants; a unique treatment for Duchenne dystrophy, which has hitherto been incurable; a study looking at the use of a helium oxygen mixture in intensive care and to treat acute bronchiolitis; and studies into the impact of various allergic problems on sleep and daytime behaviour.

The unit is funded by St. Marys Paddington Charitable Trust and the George John and Sheilah Livanos Charitable Trust. Jane Miles, Chief Executive of St Marys Charity, explained: When awarding grants our focus is on innovation and excellence and this new paediatric research unit is a wonderful example of these qualities.

We believe such specialised research is essential in order to develop treatments and care that meet the very specific needs of some of the sickest children across the UK.


'"/>




Related medicine news :

1. Good carb, bad carb? Experts debate.
2. Spread Of Rocky Mountain Spotted Fever Is A Probability, Say Experts
3. Experts Recommend Preventive Measures For Avian Flu To Begin From Farms
4. Experts Insist That Neonatal Herpes Be Reported Regularly
5. Experts State Strategies To Increase Good Cholesterol
6. Cancer Can Recur Any Time, Experts Caution
7. Experts Building Bird Flu Warning System
8. Human Growth Hormone (HGH) - View of Experts
9. Experts urging artery screening in the UK
10. Genetic Experts of Hopkins Assists In Identifying Hurricane Katrina Victims
11. Birds Being Shot Owing To Bird Flu Fear: Wildlife Experts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... Olathe, KS (PRWEB) , ... April 28, 2017 ... ... system have typically been previously exposed to more adverse experiences than children in ... have experienced trauma such as abuse, neglect or other family challenges. While no ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... the Creator responds to and which He does not. Yisrayl says with so many ... is the true name, but he says with a little Scripture, backed with a lot ...
(Date:4/28/2017)... ... 2017 , ... Intellitec Solutions announced the publication of a ... Dynamics GP solution that integrates to their PointClickCare EHR software package. With the ... Brooke Grove now has the capability to achieve its goal for a comprehensive ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor that ... his presence to an educational purpose as the host of the “Informed” series. The ... In a recent episode, the series focuses on thyroid cancer. , Although thyroid cancer ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and Markets ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ... offering. ... drug delivery technologies will rise from USD 20 Billion in 2015 ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables ...
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
Breaking Medicine Technology: